Long-term outcome of tacrolimus in cadaveric kidney transplantation from non-heart-beating donors.
Fukuhara
Nobuyuki
N
Department of Urology, School of Medicine, Nagoya University, 65 Tsurumai, Showa-ku, Nagoya Aichi, 466-8550 Japan. fukuhara@nagoya-med.ac.jp
Ono
Y
Y
Kinukawa
T
T
Hattori
R
R
Nishiyama
N
N
Yamada
S
S
Kamihira
O
O
Ohshima
S
S
D002102:Cadaver; D016572:Cyclosporine / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology; D006085:Graft Survival; D006323:Heart Arrest; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000601:surgery; D016030:Kidney Transplantation / Q000276:immunology / Q000401:mortality / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D009392:Nephrectomy; D015996:Survival Rate; D016559:Tacrolimus / Q000627:therapeutic use; D013997:Time Factors; D014019:Tissue Donors; D020858:Tissue and Organ Harvesting; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus